Nordic Life Science 1
”WE NEED TO ALIGN OUR CROSS-BORDER CHALLENGES SO
PEOPLE HAVE INCENTIVES TO WORK AND LIVE ON DIFFERENT SIDES OF ØRESUND. FURTHERMORE, WE NEED TO FIND A WAY TO ACCESS AND USE THE VALUABLE HEALTHCARE DATA THAT EXISTS IN BOTH OUR COUNTRIES IN CROSS-BORDER COLLABORATION PROJECTS.” ANE T T E S TEENBERG founded in 1997, is a non-profit membership organization in the DanishSwedish life science cluster Medicon Valley. The alliance today has more than 300 members, including Region Capital Copenhagen and Region Skåne, Lund, Malmö and Copenhagen Universities, life science parks and private companies on both side of Øresund. On November 1st, 2021, Anette Steenberg replaced Petter Magnusson Hartman as the organization’s new CEO. Søren Bregenholt, Chairman of MVA’s Board of Directors, said after the appointment was announced that Steenberg would play a key role in the Alliance’s ongoing efforts to strengthen the framework conditions for life science in Medicon Valley. Steenberg herself believes that Medicon Valley has the opportunity to become a world class life science region producing and attracting some of the best talent, research and companies in the world. This will accelerate the virtuous circle of being a top life science cluster region, she says. “I’m looking forward to strengthening the Medicon Valley cross-border cooperation and helping to increase the visibility and strongholds of Medicon Valley internationally for the benefit of our members,” Steenberg says. To her new role Anette Steenberg brings both local and global life science experience and as a red thread throughout her career she has been working with promotion of strongholds, growth and internationalization of companies. Her degree in international trade and negotiation from Denmark has been supplemented with business studies from Ecole Commerciale de la Chambre de Commerce et d’Industrie in Paris, market access studies from Singapore Institute of Management and a leadership education from Harvard Executive Business School. These studies have been combined with approximately 14 years of working abroad as a diplomat, primarily focusing on government-to-government relations and internationalization of companies both outward- and inward-bound (exports and attracting foreign director investment). “The past ten years I have especially been working with the life science sector both in public and private companies. Most recently, prior to stepping into the CEO role at MVA, I was Director for Investment Promotion at Copenhagen Capacity, attracting Foreign Direct Investment including life science investment to the Greater Copenhagen region,” Steenberg says. NORDICLIFESCIENCE.ORG 25